{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:45Z","timestamp":1767854145511,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T00:00:00Z","timestamp":1436054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00259-015-3117-3","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T23:55:09Z","timestamp":1435967709000},"page":"2013-2020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study"],"prefix":"10.1007","volume":"42","author":[{"given":"S.","family":"Djelbani-Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. O.","family":"Chandesris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Canioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brouzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hanssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Durupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Grosbois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Besnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Beyne-Rauzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Agap\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Y.","family":"Jeandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Fain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,5]]},"reference":[{"issue":"15","key":"3117_CR1","first-page":"1629","volume":"55","author":"O Fain","year":"2005","unstructured":"Fain O, Stirnemann J, Lortholary O. Systemic mastocytosis. Rev Prat. 2005;55(15):1629\u201336.","journal-title":"Rev Prat"},{"issue":"13","key":"3117_CR2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2012-09-458521","volume":"121","author":"J Gotlib","year":"2013","unstructured":"Gotlib J, Pardanani A, Akin C, Reiter A, George T, Hermine O, et al. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood. 2013;121(13):2393\u2013401.","journal-title":"Blood"},{"issue":"3","key":"3117_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215\u201325.","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"3117_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603\u201325.","journal-title":"Leuk Res"},{"key":"3117_CR5","doi-asserted-by":"crossref","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers. J Nucl Med. 2013.","DOI":"10.2967\/jnumed.112.110890"},{"key":"3117_CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1182\/asheducation.V2012.1.322.3800161","volume":"2012","author":"M Hutchings","year":"2012","unstructured":"Hutchings M. How does PET\/CT help in selecting therapy for patients with Hodgkin lymphoma? Hematol Am Soc Hematol Educ Program. 2012;2012:322\u20137.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3117_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/asheducation.V2012.1.397.3798512","volume":"2012","author":"CH Moskowitz","year":"2012","unstructured":"Moskowitz CH. Interim PET-CT in the management of diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program. 2012;2012:397\u2013401.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"11","key":"3117_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.rlu.0000242685.55001.67","volume":"31","author":"K Inoue","year":"2006","unstructured":"Inoue K, Okada K, Harigae H, Taki Y, Goto R, Kinomura S, et al. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Clin Nucl Med. 2006;31(11):721\u20133.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"3117_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/RLU.0b013e318148b467","volume":"32","author":"M Nakajo","year":"2007","unstructured":"Nakajo M, Jinnouchi S, Inoue H, Otsuka M, Matsumoto T, Kukita T, et al. FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment. Clin Nucl Med. 2007;32(10):775\u20138.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"3117_CR10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.rlu.0000178029.47624.66","volume":"30","author":"SC Burrell","year":"2005","unstructured":"Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET imaging. Clin Nucl Med. 2005;30(10):674.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"3117_CR11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2214\/ajr.179.5.1791235","volume":"179","author":"G Zettinig","year":"2002","unstructured":"Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, et al. FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol. 2002;179(5):1235\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"3117_CR12","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.leukres.2007.04.008","volume":"31","author":"Y Kim","year":"2007","unstructured":"Kim Y, Weiss LM, Chen YY, Pullarkat V. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma. Leuk Res. 2007;31(12):1749\u201354.","journal-title":"Leuk Res"},{"issue":"3","key":"3117_CR13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/RLU.0b013e3181638e5e","volume":"33","author":"RT Tomihama","year":"2008","unstructured":"Tomihama RT, McEachen JC, Kuo PH. Imaging of systemic mastocytosis by FDG-PET\/CT demonstrates increased activity in cortical bone. Clin Nucl Med. 2008;33(3):220\u20133.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"3117_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/10428194.2010.550072","volume":"52","author":"P Valent","year":"2011","unstructured":"Valent P, Sotlar K, Horny HP. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms. Leuk Lymphoma. 2011;52(5):740\u20134.","journal-title":"Leuk Lymphoma"},{"key":"3117_CR15","doi-asserted-by":"crossref","unstructured":"Dong A, Wang Y, Gao L, Zuo C. 18F-FDG PET\/CT findings in a patient with sweet syndrome associated with myelodysplastic syndrome. Clin Nucl Med. 2013.","DOI":"10.1097\/RLU.0b013e318279fd93"},{"issue":"10","key":"3117_CR16","first-page":"1854","volume":"36","author":"RS Brown","year":"1995","unstructured":"Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med. 1995;36(10):1854\u201361.","journal-title":"J Nucl Med"},{"issue":"8","key":"3117_CR17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00256-012-1374-9","volume":"41","author":"J Fritz","year":"2012","unstructured":"Fritz J, Fishman EK, Carrino JA, Horger MS. Advanced imaging of skeletal manifestations of systemic mastocytosis. Skeletal Radiol. 2012;41(8):887\u201397.","journal-title":"Skeletal Radiol"},{"issue":"1","key":"3117_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-010-1531-0","volume":"38","author":"A Agool","year":"2010","unstructured":"Agool A, Glaudemans AW, Boersma HH, Dierckx RA, Vellenga E, Slart RH. Radionuclide imaging of bone marrow disorders. Eur J Nucl Med Mol Imaging. 2010;38(1):166\u201378.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"3117_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.leukres.2010.06.010","volume":"35","author":"M Vanderhoek","year":"2010","unstructured":"Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leuk Res. 2010;35(3):310\u20136.","journal-title":"Leuk Res"},{"issue":"2","key":"3117_CR20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-methionine PET\/CT\u2013initial experience. Radiology. 2007;242(2):498\u2013508.","journal-title":"Radiology"},{"issue":"9","key":"3117_CR21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00259-013-2435-6","volume":"40","author":"E Itti","year":"2013","unstructured":"Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Vera P, et al. An international confirmatory study of the prognostic value of early PET\/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and DeltaSUVmax. Eur J Nucl Med Mol Imaging. 2013;40(9):1312\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3117-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3117-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3117-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T15:01:58Z","timestamp":1599231718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3117-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,5]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3117"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3117-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,5]]}}}